HF Advisory Group LLC Boosts Holdings in CVS Health Co. (NYSE:CVS)

HF Advisory Group LLC raised its holdings in CVS Health Co. (NYSE:CVS) by 35.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,926 shares of the pharmacy operator’s stock after buying an additional 3,643 shares during the quarter. HF Advisory Group LLC’s holdings in CVS Health were worth $1,100,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Live Oak Investment Partners purchased a new stake in shares of CVS Health during the 4th quarter worth about $25,000. Atticus Wealth Management LLC grew its holdings in shares of CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the period. Cornerstone Planning Group LLC grew its holdings in shares of CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the period. ZRC Wealth Management LLC grew its holdings in shares of CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 400 shares during the period. Finally, True Wealth Design LLC purchased a new stake in shares of CVS Health during the 4th quarter worth about $48,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS traded up $0.43 during trading hours on Thursday, hitting $69.03. 1,495,656 shares of the stock were exchanged, compared to its average volume of 10,776,160. The stock has a 50-day simple moving average of $75.53 and a 200-day simple moving average of $73.73. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The stock has a market cap of $87.01 billion, a price-to-earnings ratio of 10.71, a price-to-earnings-growth ratio of 0.91 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the business posted $1.99 earnings per share. The firm’s revenue for the quarter was up 11.9% on a year-over-year basis. Analysts anticipate that CVS Health Co. will post 8.32 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.85%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

Analyst Ratings Changes

A number of equities analysts have weighed in on CVS shares. Piper Sandler upped their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Barclays started coverage on CVS Health in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a report on Wednesday, April 10th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Finally, Royal Bank of Canada decreased their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $89.44.

Insider Buying and Selling

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is currently owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.